Celanese (CE) Proxy Filing summary

Executive summary

• 2024 was a challenging year, but leadership changes and strategic actions were taken to position the company for long-term success and value creation.

• Scott Richardson was appointed CEO, and three new directors joined the Board, bringing significant industry, financial, and operational expertise.

• A new Finance and Business Review Committee was formed to oversee financial strategy, cost reduction, cash flow prioritization, and deleveraging.

• The company is focused on increasing cash flow, reducing costs, and driving top-line growth, with a renewed emphasis on operational efficiency and competitive positioning.

Voting matters and shareholder proposals

• Shareholders will vote on the election of 13 directors, ratification of KPMG LLP as independent auditor, advisory approval of executive compensation, and amendments to remove supermajority voting requirements.

• Four management proposals seek to replace 80% supermajority voting thresholds with majority vote standards for by-law and charter amendments, board seat filling, and director removal.

• A shareholder proposal requests simple majority voting for all charter and by-law amendments; the Board recommends voting against it, citing redundancy with management's proposals.

Board of directors and corporate governance

• The Board is composed of 13 nominees, 12 of whom are independent, with a mix of tenure and diverse backgrounds.

• Board refreshment has been ongoing, with eight new directors since 2022 and a transition to an independent Chair in 2025.

• Committees include Audit, Compensation and Management Development, Nominating and Corporate Governance, Stewardship, and Finance and Business Review.

• Annual self-evaluations and succession planning are integral to governance practices.

• Shareholder rights include annual director elections, majority voting, proxy access, and no poison pill.